(Q43928839)

28 November 2017

title

Antineutrophil cytoplasmic antibodies in Bulgarian patients with rheumatoid arthritis: characterization and clinical associations (English)

1 reference

28 November 2017

0 references

1 reference

Irena Manolova

1

1 reference

28 November 2017

Maria Dantcheva

series ordinal

2

1 reference

28 November 2017

publication date

11 November 2004

1 reference

Rheumatology International

28 November 2017

published in

1 reference

28 November 2017

volume

26

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

107-114

1 reference

Antineutrophil Cytoplasmic Autoantibodies Antigen Specificity

28 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-004-0517-2

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00296-004-0517-2

Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies

21 January 2018

1 reference

12 December 2020

Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis

1 reference

12 December 2020

Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis

1 reference

12 December 2020

Comparative effects of antilactoferrin antibodies and tumor necrosis factor on neutrophil adherence to matrix proteins.

1 reference

12 December 2020

Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA)

1 reference

12 December 2020

Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy

1 reference

12 December 2020

Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3.

1 reference

12 December 2020

Anti-neutrophil cytoplasm antibodies 1988

1 reference

12 December 2020

Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis

1 reference

12 December 2020

Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations

1 reference

12 December 2020

Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease

1 reference

12 December 2020

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

12 December 2020

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

1 reference

12 December 2020

The subclass distribution of human IgG rheumatoid factor.

1 reference

12 December 2020

Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns

1 reference

12 December 2020

Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis

1 reference

12 December 2020

The current status of neutrophil cytoplasmic antibodies

1 reference

12 December 2020

Prevalence and clinical significance of anti-lactoferrin autoantibodies in inflammatory bowel diseases and primary sclerosing cholangitis.

1 reference

12 December 2020

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

1 reference

12 December 2020

Therapeutic criteria in rheumatoid arthritis

1 reference

12 December 2020

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

1 reference

12 December 2020

Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders

1 reference

12 December 2020

Leucocyte activation by anti-lactoferrin antibodies bound to vascular endothelium

1 reference

12 December 2020

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease

1 reference

12 December 2020

IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA)

1 reference

12 December 2020

Absence of circulating antineutrophil cytoplasm antibodies (ANCA) in severe vasculitis associated with rheumatoid arthritis

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process

1 reference

12 December 2020

Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus

1 reference

12 December 2020

Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis

1 reference

12 December 2020

Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin

1 reference

12 December 2020

Delineation of a standard procedure for indirect immunofluorescence detection of ANCA

1 reference

12 December 2020

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

12 December 2020

Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies

1 reference

12 December 2020

Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: a prospective study

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance

1 reference

12 December 2020

Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases

1 reference

12 December 2020

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

1 reference

12 December 2020

Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis

1 reference

12 December 2020

Immunoglobulin isotypes of anti-myeloperoxidase and anti-lactoferrin antibodies in patients with collagen diseases

1 reference

12 December 2020

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass

1 reference

12 December 2020

10.1007/S00296-004-0517-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 November 2017

1034476163

0 references

1 reference